We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


The Researchers Who Are Changing the Story of Ovarian Cancer

We hear from Cambridge researchers leading a pioneering programme to help more women survive ovarian cancer.

Only 43% of women in England survive five years beyond their ovarian cancer diagnosis. Professors James Brenton and Evis Sala aim to change this.

Their research at the Mark Foundation Institute for Integrated Cancer Medicine at the Cancer Research UK (CRUK) Cambridge Centre is bringing together complex data (clinical features, imaging, genomic data, molecular tests, tumour pathology, treatment outcomes and so on) with machine learning techniques to help clinicians make better decisions for patients, not just in Cambridge but across the UK and the world.